(Q34469129)

English

Bone mineral density in well-differentiated thyroid cancer patients treated with suppressive thyroxine: a systematic overview of the literature

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

Europe PubMed Central

Bone mineral density in well-differentiated thyroid cancer patients treated with suppressive thyroxine: a systematic overview of the literature (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

differentiated thyroid carcinoma

1 reference

based on heuristic

inferred from title

author name string

May Lynn Quan

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Janice L Pasieka

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Otto Rorstad

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Journal of Surgical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

79

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

62-9; discussion 69-70

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Markers of bone turnover in patients with differentiated thyroid cancer with and following withdrawal of thyroxine suppressive therapy.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10043

21 January 2018

Bone mineral density in children and adolescent females treated with high doses of L-thyroxine

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10043

21 January 2018

Biochemical assessment of bone loss in patients on long-term thyroid hormone treatment.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10043

21 January 2018

Skeletal integrity in premenopausal and postmenopausal women receiving long-term L-thyroxine therapy

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10043

21 January 2018

Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10043

21 January 2018

Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10043

21 January 2018

Bone mineral density in patients receiving suppressive doses of thyroxine for differentiated thyroid carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10043

21 January 2018

Skeletal integrity in men chronically treated with suppressive doses of L-thyroxine.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10043

21 January 2018

A longitudinal assessment of bone loss in women with levothyroxine-suppressed benign thyroid disease and thyroid cancer

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10043

21 January 2018

Effects of suppressive doses of levothyroxine treatment on sex-hormone-binding globulin and bone metabolism

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10043

21 January 2018

Bone changes in pre- and postmenopausal women with thyroid cancer on levothyroxine therapy: evolution of axial and appendicular bone mass

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10043

21 January 2018

Possible Limited Bone Loss with Suppressive Thyroxine Therapy Is Unlikely to Have Clinical Relevance

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10043

21 January 2018

Long-term thyroxine treatment and bone mineral density

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10043

21 January 2018

Spinal bone mass after long-term treatment with L-thyroxine in postmenopausal women with thyroid cancer and chronic lymphocytic thyroiditis

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10043

21 January 2018

Thyroxine suppressive therapy decreases bone mineral density in post-menopausal women

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10043

21 January 2018

Bone density and mineral metabolism in thyroidectomized patients treated with long-term L-thyroxine

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10043

21 January 2018

Bone minerals and levothyroxine

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10043

21 January 2018

Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10043

21 January 2018

Identifiers

10.1002/JSO.10043

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34469129&oldid=1948982689"